Zahra Kadri
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 2
- Genetics top 10%
- Hemoglobinopathies and Related Disorders 5
-
- Erythrocyte Function and Pathophysiology 5
-
- Signaling Pathways in Disease 3
- Epigenetics and DNA Methylation 2
- Protein Degradation and Inhibitors 2
- RNA modifications and cancer 2
- Protein Kinase Regulation and GTPase Signaling 2
- Co-authors
- Stany ChrétienPatrick MayeuxPhilippe LeboulchCatherine LacombeFrédèrique VerdierE. PetitfrereCédric BoudotBernard Haye
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- FranceUnited StatesThailand
In The Last Decade
Zahra Kadri
17 papers receiving 525 citations
Peers
Comparison fields: 5 of 68
- Hematology 190
- Genetics 99
- Cancer Research 105
- Oncology 137
- Physiology 117
Countries citing papers authored by Zahra Kadri
This map shows the geographic impact of Zahra Kadri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zahra Kadri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zahra Kadri more than expected).
Fields of papers citing papers by Zahra Kadri
This network shows the impact of papers produced by Zahra Kadri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zahra Kadri. The network helps show where Zahra Kadri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zahra Kadri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 5 | |
| 2 | 2020 | 3 | |
| 3 | 2019 | 0 | |
| 4 | 2017 | 4 | |
| 5 | 2016 | 7 | |
| 6 | 2015 | 36 | |
| 7 | 2013 | 22 | |
| 8 | 2012 | 15 | |
| 9 | 2009 | 57 | |
| 10 | 2009 | 22 | |
| 11 | 2005 | 51 | |
| 12 | 2004 | 134 | |
| 13 | 2003 | 18 | |
| 14 | 2003 | 78 | |
| 15 | 2002 | 18 | |
| 16 | 2000 | 21 | |
| 17 | Erythropoietin induction of tissue inhibitors of metalloproteinase-1 expression and secretion is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways. | 2000 | 30 |
| 18 | 1999 | 16 |
About Zahra Kadri
Zahra Kadri is a scholar working on Genetics, Hematology and Physiology, having authored 18 papers that have together received 537 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (5 papers), Hemoglobinopathies and Related Disorders (5 papers), Signaling Pathways in Disease (3 papers), Epigenetics and DNA Methylation (2 papers), Protein Degradation and Inhibitors (2 papers), RNA modifications and cancer (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). The work is most often cited by research in Hematology (190 citations), Genetics (99 citations) and Cancer Research (105 citations). Zahra Kadri has collaborated with scholars based in France, United States and Thailand. Frequent co-authors include Stany Chrétien, Patrick Mayeux, Philippe Leboulch, Catherine Lacombe, Frédèrique Verdier, E. Petitfrere, Cédric Boudot, Bernard Haye, Paul‐Henri Roméo and Elise Lambert. Their work appears in journals such as Journal of Biological Chemistry, Genes & Development and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.